Relief Therapeutics Holding SA (RLFTF)
OTCMKTS · Delayed Price · Currency is USD
4.060
-0.240 (-5.58%)
Oct 2, 2025, 2:18 PM EDT
RLFTF Market Cap
RLFTF has a market cap or net worth of $51.46 million as of October 2, 2025. Its market cap has increased by 65.67% in one year.
Market Cap
51.46M
Enterprise Value
38.19M
Revenue
5.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.06
Market Cap Chart
Since July 19, 2016, RLFTF's market cap has decreased from 93.95M to 51.46M, a decrease of -45.22%. That is a compound annual growth rate of -6.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 51.46M | -11.59% |
| Dec 30, 2024 | 58.21M | 96.41% |
| Dec 29, 2023 | 29.64M | -79.23% |
| Dec 30, 2022 | 142.71M | -52.45% |
| Dec 30, 2021 | 300.10M | -69.64% |
| Dec 30, 2020 | 988.40M | 45,169.87% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 713.40M |
| Glass House Brands | 610.83M |
| Northwest Biotherapeutics | 378.06M |
| CytoDyn | 326.51M |
| Nika Pharmaceuticals | 301.74M |
| American Oncology Network | 287.63M |
| Silence Therapeutics | 240.89M |